Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SSB Expands PAT Portfolio by Adding Sensor Technology for Real-Time Biomass Measurement

Published: Friday, March 01, 2013
Last Updated: Thursday, February 28, 2013
Bookmark and Share
Exclusive global sales and development alliance with Aber Instruments.

Sartorius Stedim Biotech (SSB) has entered into a global sales and development partnership with Aber Instruments (Aber), a Welsh company for bioprocess and brewing equipment.

Aber is a highly specialized supplier of sensor technology that is used by the biopharmaceutical industry for in-line biomass measurement in cell cultivation and fermentation processes.

Based on this cooperation, SSB has secured exclusive global marketing and distribution rights to Aber‘s single-use sensor technology for the biopharmaceutical market.

As agreed, Aber will supply SSB with measuring instruments. SSB will manufacture the biomass sensors under license, integrate these into its single-use bioreactors and exclusively market these products in a dual-branding arrangement. New single-use sensors will be developed by both companies.

SSB has continuously expanded its process analytics portfolio over the past years in the area of single-use sensors to enable real-time, non-invasive measurement of critical process parameters such as pH, dissolved oxygen content, temperature, glucose, lactate and biomass.

“Single-use sensors make our disposable bags even more intelligent,” comments Stefan Schlack, Senior Vice President of Marketing at SSB. “They deliver real-time information about the progress of cell culture processes and help biopharmaceutical customers to understand their processes even better and further optimize them - a decisive competitive advantage.”

In-line biomass sensors enable precise and reproducible information to be obtained on the progress of a fermentation process, without having to take samples and analyze these in the laboratory.

As a result, cells are not unnecessarily exposed to stress caused by manual sampling and contamination risks are eliminated.

In conjunction with SSB‘s existing PAT and software solutions, biomass sensors represent high-performance tools for modeling and optimizing biopharmaceutical development and manufacturing processes, as well as for further accelerating development times.

Dr. John Carvell, Sales and Marketing Director at Aber Instruments, is pleased about collaborating with SSB: “Based on SSB’s global sales and distribution network, we can make our technology accessible to an even wider group of customers. SSB has in-depth expertise in single-use technology and is thoroughly versed in bioprocesses. Together with our profound knowledge of in-line biomass measurement, both companies stand to benefit from the joint development of new sensors.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sartorius Acquires U.S. Start-Up kSep Systems
Transaction to expand SSB’s bioprocessing product portfolio with innovative single-use centrifuges.
Thursday, July 07, 2016
Sartorius Apprenticeship Scheme Honoured
Cambridge regional college awards recognises firm’s outstanding apprenticeship scheme.
Wednesday, March 23, 2016
Sartorius Stedim Biotech and GE Healthcare Sign Worldwide OEM Supply Agreement
Expands GE’s start-to-finish offering for cost efficient manufacture of biopharmaceuticals.
Tuesday, September 01, 2015
Miriam Monge to Join Sartorius Stedim Biotech
Company appoints Miriam Monge as director of marketing for integrated solutions.
Wednesday, August 27, 2014
Sartorius Stedim Announces Offer to Acquire TAP Biosystems
Sartorius Stedim Biotech to further expand its portfolio of single-use fermentors.
Tuesday, October 08, 2013
Sartorius Appoints Senior Vice President
Appointment of Stefan Schlack as Senior Vice President of marketing.
Thursday, October 25, 2012
SSB and Bosch Announce Global Collaboration
Agreement covers the mutual design and development of single-use filling solutions.
Thursday, June 21, 2012
SSB and Refine Technology Announce Cooperation
Development of a robust, easy-to-use platform for high-density cell cultivation.
Tuesday, January 24, 2012
SSB and G-Con Manufacturing Announce Global Collaboration
Collaboration will support faster and more flexible facility construction and shortened time to market.
Thursday, January 19, 2012
Sartorius Stedim Biotech and GE Healthcare Life Sciences Sign Cross-Licensing Agreement
Agreement covers intellectual property relating to biopharmaceutical manufacturing technologies.
Monday, September 12, 2011
SSB and Südpack Medica AG Sign Exclusive Cooperation Agreement
Südpack and SSB cooperate in the manufacture of plastic film.
Friday, June 17, 2011
Sartorius Stedim Biotech and RAUMEDIC Sign Partnership Agreement
SSB’s product portfolio to be extended by tubing and polymer components.
Friday, May 20, 2011
Scientific News
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
New data shows Sandoz biosimilar candidate has equivalent efficacy to originator etanercept following comparison in psoriasis.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!